DB16643ApprovedVaccines
Influenza A virus subtype H1N1 haemagglutinin, recombinant: Overview.
- First approval
- Canada, 2021 · European Union, 2021
- Also known as
- Recombinant haemagglutinin protein-strain A (H1N1)
- Brand names
What you can answer from here — as of January 20, 2026
Which companies are running trials of Influenza A virus subtype H1N1 haemagglutinin, recombinant, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account